603811.SH
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 6.48
+1.09%Oct 22, 2026, 08:58 UTC
Cheng Yi Pharmaceutical director and deputy general manager Zhang Zhihong sold 400,000 company shares through centralized bidding from July 23 to October 22, 2026, for a total of RMB 2.816 million.
Source:Sep 30, 2026, 08:05 UTC
Zhejiang Cheng Yi Pharmaceutical CFO Lü Sunzhan completed a plan to sell 453,800 shares, or 0.10% of the company's total share capital, via centralized bidding between July 23 and September 29, 2026.
Source:Aug 26, 2026, 07:54 UTC
Chengyi Pharmaceutical announced its first-half 2026 results: revenue of 432 million yuan, up 3.63% year-on-year, and net profit attributable to shareholders of 94.8687 million yuan, down 15.61% year-on-year.